BIOLASE, INC. Deferred Tax Assets, Net of Valuation Allowance
BIOLASE, INC. had Deferred Tax Assets, Net of Valuation Allowance of $1.26 million as of 2023-12-31, per its 10-K filed 2024-03-21.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2024-03-21
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.26M.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.33M.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.29M.
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.43M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2023-12-31 | $1.26M 10-K · filed 2024-03-21 |
| 2022-12-31 | $1.33M 10-K · filed 2024-03-21 |
| 2021-12-31 | $1.29M 10-K · filed 2023-03-28 |
| 2020-12-31 | $1.43M 10-K · filed 2022-03-17 |
| 2019-12-31 | $1.05M 10-K · filed 2021-03-31 |
| 2018-12-31 | $758.00K 10-K · filed 2020-03-30 |
| 2017-12-31 | $689.00K 10-K · filed 2019-03-08 |
| 2016-12-31 | $432.00K 10-K · filed 2018-03-14 |
| 2015-12-31 | $136.00K 10-K · filed 2017-03-10 |
| 2014-12-31 | $134.00K 10-K · filed 2016-03-11 |
| 2013-12-31 | $138.00K 10-K · filed 2015-03-06 |
| 2012-12-31 | $175.00K 10-K · filed 2014-03-17 |
| 2011-12-31 | $145.00K 10-K · filed 2013-03-15 |